International Journal of Biological Macromolecules,
Journal Year:
2025,
Volume and Issue:
unknown, P. 142887 - 142887
Published: April 1, 2025
Amyloid-beta
(Aβ)
and
tubulin-associated
unit
(tau)
proteins
are
key
biomarkers
of
Alzheimer's
disease
(AD),
detectable
by
Positron
Emission
Tomography
(PET)
imaging
Cerebrospinal
Fluid
(CSF)
assays.
They
reflect
insoluble
fibrils
in
the
brain
soluble
monomers
cerebrospinal
fluid,
respectively.
PET
CSF
have
been
utilized
diagnosing
AD;
however,
their
incomplete
agreement
significantly
confounds
early
detection.
Additionally,
molecular
mechanisms
underlying
dynamics
AD
remain
elusive
yet
to
be
quantitatively
revealed.
To
answer
these
questions,
we
develop
a
multiscale
mathematical
model
that
characterizes
various
forms
biomarkers,
including
molecules
diffusive
across
regions,
brain.
Mathematical
modeling
enables
explanation
asynchronous
trajectory
biomarkers.
Our
captures
spatiotemporal
Aβ
tau
with
neurodegeneration
AD.
Simulation
results
demonstrate
PET-CSF
discordance
is
typical
stage
natural
history
protein
aggregation,
becoming
abnormal
before
onset
abnormality.
Furthermore,
correlation
analysis
reveals
more
strongly
associated
tau-PET
than
Aβ-PET.
These
findings
suggest
recognized
as
biomarker
at
AD,
while
suitable
for
assessment.
The
proposed
explains
neurobiological
factors
contributing
offers
valuable
tool
improving
detection
treatment
strategies
clinical
trials.
Alzheimer s & Dementia,
Journal Year:
2024,
Volume and Issue:
20(8), P. 5695 - 5719
Published: July 5, 2024
Abstract
Sex
and
gender—biological
social
constructs—significantly
impact
the
prevalence
of
protective
risk
factors,
influencing
burden
Alzheimer's
disease
(AD;
amyloid
beta
tau)
other
pathologies
(e.g.,
cerebrovascular
disease)
which
ultimately
shape
cognitive
trajectories.
Understanding
interplay
these
factors
is
central
to
understanding
resilience
resistance
mechanisms
explaining
maintained
function
reduced
pathology
accumulation
in
aging
AD.
In
this
narrative
review,
ADDRESS!
Special
Interest
Group
(Alzheimer's
Association)
adopted
a
multidisciplinary
approach
provide
foundations
recommendations
for
future
research
into
sex‐
gender‐specific
drivers
resilience,
including
sex/gender‐oriented
review
genetics,
AD
non‐AD
pathologies,
brain
structure
function,
animal
research.
We
urge
field
adopt
sex/gender‐aware
advance
our
intricate
biological
determinants
consider
sex/gender‐specific
throughout
stages.
Highlights
differences
decline
vary
by
age
status.
Initial
evidence
supports
sex‐specific
distinctions
pathology.
Findings
suggest
sex
on
cognition.
There
change
transition
clinical
Gender
warrant
study:
modifiable,
immune,
inflammatory,
vascular.
Science Advances,
Journal Year:
2025,
Volume and Issue:
11(10)
Published: March 5, 2025
Women
live
longer
than
men
and
exhibit
less
cognitive
aging.
The
X
chromosome
contributes
to
sex
differences,
as
females
harbor
an
inactive
(Xi)
active
(Xa),
in
contrast
males
with
only
Xa.
Thus,
reactivation
of
silent
Xi
genes
may
contribute
differences.
We
use
allele-specific,
single-nucleus
RNA
sequencing
show
that
aging
remodels
transcription
the
Xa
across
hippocampal
cell
types.
Aging
preferentially
changed
gene
expression
on
X's
relative
autosomes.
Select
underwent
activation,
new
escape
cells
including
dentate
gyrus,
critical
learning
memory.
Expression
escapee
Plp1,
a
myelin
component,
was
increased
hippocampus
female
mice
parahippocampus
women.
AAV-mediated
Plp1
elevation
gyrus
male
improved
cognition.
Understanding
how
confer
advantage
could
lead
novel
targets
counter
brain
disease
both
sexes.
JAMA Neurology,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Sept. 9, 2024
Importance
The
X
chromosome
has
remained
enigmatic
in
Alzheimer
disease
(AD),
yet
it
makes
up
5%
of
the
genome
and
carries
a
high
proportion
genes
expressed
brain,
making
particularly
appealing
as
potential
source
unexplored
genetic
variation
AD.
Objectives
To
perform
first
large-scale
chromosome–wide
association
study
(XWAS)
Design,
Setting,
Participants
This
was
meta-analysis
studies
case-control,
family-based,
population-based,
longitudinal
AD-related
cohorts
from
US
Alzheimer’s
Disease
Genetics
Consortium,
Sequencing
Project,
UK
Biobank,
Finnish
health
registry,
Million
Veterans
Program.
Risk
AD
evaluated
through
case-control
logistic
regression
analyses.
Data
were
analyzed
between
January
2023
March
2024.
Genetic
data
available
high-density
single-nucleotide
variant
microarrays
whole-genome
sequencing
summary
statistics
for
multitissue
expression
protein
quantitative
trait
loci
published
included,
enabling
follow-up
colocalization
A
total
1
629
863
eligible
participants
selected
referred
volunteer
samples,
477
596
whom
excluded
analysis
exclusion
criteria.
number
who
declined
to
participate
original
not
available.
Main
Outcome
Measures
AD,
reported
odds
ratios
(ORs)
with
95%
CIs.
Associations
considered
at
(
P
<
×
10
−5
)
genome-wide
5
−8
significance.
Primary
analyses
are
nonstratified,
while
secondary
evaluate
sex-stratified
effects.
Results
Analyses
included
152
284
non-Hispanic
White,
European
ancestry
(664
403
[57.7%]
female
487
881
[42.3%]
male),
including
138
558
individuals
Six
independent
passed
significance,
4
showing
support
links
signal
nearby
brain
nonbrain
tissues.
One
these
conservative
its
lead
centered
on
an
intron
SLC9A7
(OR,
1.03;
CI,
1.02-1.04)
prioritizing
both
CHST7
genes.
Of
6
loci,
displayed
evidence
escape
inactivation
regard
risk.
Conclusion
Relevance
XWAS
identified
novel
locus.
regulates
pH
homeostasis
Golgi
secretory
compartments
is
anticipated
have
downstream
effects
amyloid
β
accumulation.
Overall,
this
advances
our
knowledge
genetics
may
provide
biological
drug
targets.
results
further
initial
insights
into
elucidating
role
sex-based
differences
Frontiers in Aging Neuroscience,
Journal Year:
2025,
Volume and Issue:
17
Published: March 4, 2025
We
reviewed
the
literature
on
sex
differences
in
genetically
determined
Alzheimer’s
disease
(AD),
focusing
autosomal
dominant
AD
(ADAD),
Down
syndrome-associated
(DSAD),
and
APOE4
homozygosity,
particularly
regarding
penetrance,
symptom
onset
clinical
progression,
trajectories
for
markers
of
amyloidosis
(A),
tau
pathology
(T)
neurodegeneration
(N).
Data
suggests
that
onset,
AT(N)
biomarker
are
typically
subtle
populations.
Noteworthy
exceptions,
such
as
increased
later
stages
females
while
similar
cognitive
outcomes,
suggest
a
potential
differential
reserve
warrants
further
investigation.
Additionally,
interaction
between
APOE
genotype
reveals
complex
multifaceted
effects
DSAD,
with
implications
ADAD
remain
underexplored.
The
smaller
observed
compared
to
sporadic
offer
insights
into
different
underlying
mechanisms
Future
research
should
prioritize
sex-specific
investigations
AD,
refining
methodologies.
This
includes
prioritizing
longitudinal
designs,
adjustment
key
confounders,
adherence
guidelines.
Neurology,
Journal Year:
2025,
Volume and Issue:
104(8)
Published: March 31, 2025
The
prevalence
and
impact
of
stressful
life
events
(SLEs)
on
age-related
Alzheimer
disease
(AD)-related
pathways
may
depend
social
determinants
including
gender
education.
We
investigated
whether
specific
SLEs
are
associated
with
AD
pathology
neurodegeneration
how
these
associations
differ
by
This
cross-sectional
study
included
cognitively
unimpaired
participants,
most
a
family
history
sporadic
AD,
from
the
ALzheimer's
FAmilies
(ALFA)
cohort,
based
in
Barcelona,
Spain.
Participants
had
available
assessments
occurrence
type
lifetime
lumbar
puncture
and/or
structural
MRI.
performed
multiple
regression
analyses
to
examine
SLE
(1)
pathologies
(CSF
phosphorylated
tau
181
[p-tau181]
β-amyloid
[Aβ]
42/40)
(2)
markers
neurogranin
GM
volumes
voxel-wise)
interaction
stratification
(women/men)
In
total,
1,290
participants
(mean
age
=
59.4
years,
range:
48-77
99%
White
61%
women)
were
(393
1,234
spectroscopic
MRI
assessments).
Less
educated
women
reported
more
grief-related
economic-related
SLEs.
Furthermore,
abuse
reproductive
Grief-related
CSF
outcomes
while
economic
MRI-based
outcomes,
both
an
age-independent
manner.
Specifically,
partner's
death
was
lower
Aβ42/40
(B
-5.19;
95%
CI
-9.61
-0.76;
p
0.022)
higher
p-tau181
0.18;
0.05-0.32;
0.007)
0.19;
0.007).
driven
less
men
women.
Unemployment
loss
limbic
frontal
areas,
women,
respectively.
Older
adults
at
risk
cognitive
decline
education
be
susceptible
experience
Men
who
have
experienced
widowhood
unemployment
financial
difficulties
benefit
interventions.
Neurology,
Journal Year:
2025,
Volume and Issue:
104(9)
Published: April 9, 2025
Female
sex
and
a
parental
history
of
Alzheimer
disease
(AD),
especially
maternal,
confer
increased
risk
AD.
Associations
between
sex,
or
affected
AD
parent's
biomarkers
are
less
clear.
We
examined
whether
influences
(1)
β-amyloid
(Aβ)
tau
burden/accumulation,
(2)
the
association
Aβ
burden,
(3)
brain
cognitive
resilience
to
burden.
The
sample
included
243
participants
from
Presymptomatic
Evaluation
Experimental
Novel
Treatments
for
cohort
in
Canada.
All
with
[18F]-NAV4694
[18F]-AV1451
PET
MRI
were
included.
differences
on
regional
burden/accumulation;
2-way
interactions
burden;
3-way
time,
deposition
hippocampal
volume
(brain
resilience)
cognition
(cognitive
over
time.
Participants
(69.4%
female)
aged
68.3
±
5.1
years
at
their
first
scans.
cognitively
unimpaired
baseline.
Longitudinal
data
available
242
(follow-up,
6.72
2.38
years),
including
238
(6.53
2.48
follow-up)
follow-ups
115
(4.4
0.6
follow-ups,
71
developed
mild
impairment.
Women
showed
greater
(standardized
β
=
0.13
0.3)
stronger
global
than
men
0.79
0.1).
Individuals
an
father
those
mother
0.65
Aβ-associated
atrophy
time
0.24
and,
surprisingly,
individuals
paternal
seemed
more
vulnerable
Aβ-related
spread
tau,
whereas
women
Aβ.
Understanding
sex-specific
could
allow
clinical
trial
precision
personalization.
A
major
limitation
reduced
analyses.
Experimental Gerontology,
Journal Year:
2024,
Volume and Issue:
198, P. 112619 - 112619
Published: Oct. 29, 2024
Aging
is
a
dynamic
process
that
requires
continuous
response
and
adaptation
to
internal
external
stimuli
over
the
life
course.
This
eventually
results
in
people
aging
differently
women
than
men.
The
"gender
paradox"
describes
how
experience
greater
longevity
men,
although
linked
with
higher
rates
of
disability
poor
health
status.
Recently,
concept
frailty
has
been
incorporated
into
this
paradox
giving
rise
"sex-frailty
which
are
frailer
because
they
manifest
worse
status
but,
at
same
time,
appear
less
susceptible
death
men
age.
However,
very
little
known
about
biological
roots
sex-related
difference
frailty.
Inflamm-aging,
chronic
low-grade
inflammatory
state
associated
age,
plays
key
pathophysiological
role
several
age-related
diseases/conditions,
including
Alzheimer's
disease
(AD),
for
have
lifetime
risk
Interestingly,
inflamm-aging
develops
different
rate
compared
features
could
play
critical
development
AD
women.
According
view,
continuum
between
diseases
probably
lacks
clear
boundaries
can
be
envisioned
shared
mechanisms
progress
pace
may
lead
trajectories
It
therefore
becomes
urgent
consider
holistic
approach
study
aging,
declining
it
from
gender
medicine
perspective
also
sex-frailty
paradox.
The Clinical Neuropsychologist,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 25
Published: Jan. 20, 2025
The
long-recognized
association
of
brain
injury
with
increased
risk
dementia
has
undergone
significant
refinement
and
more
detailed
study
in
recent
decades.
Chronic
traumatic
encephalopathy
(CTE)
is
a
specific
neurodegenerative
tauopathy
related
to
prior
exposure
repetitive
head
impacts
(RHI).
We
aim
contextualize
CTE
within
historical
perspective
among
emerging
data
which
highlights
the
scientific
conceptual
evolution
CTE-related
research
parallel
broader
field
disease
dementia.
provide
narrative
state-of-the-science
update
on
neuropathology,
clinical
manifestations,
biomarkers,
different
types
patterns
impact
relevant
for
CTE,
complicated
influence
co-pathology
symptoms.
Now
almost
20
years
since
initial
case
report
former
American
football
player,
continues
evolving
increasing
clarity
but
also
several
ongoing
controversies.
Our
understanding
neuropathology
outpaces
that
disease-specific
correlates
or
development
in-vivo
biomarkers.
Diagnostic
criteria
symptoms
attributable
are
still
being
validated,
leveraging
increasingly
available
biomarkers
other
conditions
like
Alzheimer's
may
be
helpful
informing
differential
diagnosis.
As
diagnostic
efforts
advance,
clinicians
should
care
and/or
referrals
providers
best
suited
treat
an
individual
patient's
symptoms,
many
have
evidence-based
behavioral
treatment
options
etiologically
agnostic.
Several
initiatives
gradual
accrual
gold
standard
clinico-pathological
will
pay
dividends
advancing
existing
gaps
CTE.